CERO THERAPEUTICS HOLDINGS, INC. Proceeds from Debt, Net of Issuance Costs
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Proceeds from Debt, Net of Issuance Costs of $197.53 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from debt, net of issuance costs for the quarter ending 2025-12-31 was -$735.81K.
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from debt, net of issuance costs for the quarter ending 2025-09-30 was $73.40K.
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from debt, net of issuance costs for the quarter ending 2025-06-30 was $124.13K.
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from debt, net of issuance costs for fiscal 2025 was $197.53K.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$735.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$662.41K derived: sum of 2 quarters · filed 2026-04-15 | -$538.28K derived: sum of 3 quarters · filed 2026-08-14 | $197.53K 10-K · filed 2026-04-15 |
| 2025-09-30 | $73.40K 10-Q · filed 2025-11-19 | $197.53K derived: sum of 2 quarters · filed 2026-08-14 | $933.35K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $124.13K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |